Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2013
10/17/2013WO2013153191A1 Compounds which inhibit neuronal exocytosis (ii)
10/17/2013WO2013105089A3 Anti-inflammatory peptides and use thereof
10/17/2013US20130274436 Use of aniline in the radiostabilization of oxime ligation
10/17/2013US20130274208 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
10/17/2013US20130274207 Uses of Natriuretic Peptide Constructs
10/17/2013US20130274206 Compositions and Methods for Promoting Wound Healing and Tissue Regeneration
10/17/2013US20130274205 Peptidomimetic macrocycles
10/17/2013US20130274204 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
10/17/2013US20130274202 Peptides for Treating Cancer
10/17/2013US20130274200 Selective anticancer chimeric peptide
10/17/2013US20130274187 Peptides and methods of using same
10/17/2013US20130274177 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
10/17/2013US20130274176 Beta-arrestin effectors and compositions and methods of use thereof
10/17/2013US20130273090 Antigen-norovirus p-domain monomers and dimers, antigen norovirus p-particle molecules, and methods for their making and use
10/17/2013US20130273058 Synthetic peptide inhibitors of wnt pathway
10/16/2013EP2650303A1 Methods and compositions for the treatment of heart failure and other disorders
10/16/2013EP2649985A1 Compounds which inhibit neuronal exocytosis (III)
10/16/2013EP2649984A1 Compounds which inhibit neuronal exocytosis
10/16/2013EP2649983A1 Compounds which inhibit neuronal exocytosis (II)
10/16/2013EP2649090A2 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
10/16/2013EP2649089A2 Peptide preparations and peptides with antitumour activity
10/16/2013EP2648743A2 Agents for increased resistance against oxidative stress conditions
10/16/2013CN103351428A Synthesis of degarelix by solid phase segment method
10/16/2013CN103351427A Preparation method of thymopentin
10/16/2013CN103351426A Polypeptide synthesis method for octreotide acetate
10/16/2013CN103351425A Disheveled pdz modulators
10/16/2013CN103351424A Preparation method of paclitaxel or docetaxel octreotide conjugate
10/16/2013CN103351423A Peptide vaccines for cancers expressing tumor-associated antigens
10/16/2013CN102558304B Self-assembling peptide, and application of self-assembling peptide in promoting tumor cell to form multicellular spheroid
10/16/2013CN101928330B New compound and application thereof
10/15/2013US8557978 Cross-linked glycopeptide-cephalosporin antibiotics
10/15/2013US8557961 Alpha 1-antitrypsin compositions and methods of making and using same
10/15/2013US8557958 Compositions and methods for treatment of diabetes
10/15/2013US8557957 Methods of treating disorders by administration of F11 receptor antagonists
10/15/2013US8557781 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/15/2013US8557780 Monomethylvaline compounds capable of conjugation to ligands
10/15/2013US8557777 Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
10/15/2013CA2598316C Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
10/15/2013CA2589951C Method for producing carboxy-terminal amidated peptides
10/15/2013CA2373721C Compounds that bind her2
10/10/2013WO2013151538A1 Fluorescent labeling of living cells
10/10/2013WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
10/10/2013WO2013150394A1 Antimicrobial cyclic peptide compositions for plants
10/10/2013WO2013149506A1 Chimeric peptide based on opioid peptide biphalin and neuropeptide ff and synthesis and use thereof
10/10/2013WO2013052168A3 Detection aib1-delta 4 protein
10/10/2013US20130267677 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
10/10/2013US20130267457 Peptide inhibitors of protein synthesis
10/10/2013US20130266958 Method for activating helper t cell
10/10/2013US20130266663 Sox9 inhibitors
10/10/2013US20130266604 Peptide containing multiple n-linked glycosylation sequons
10/10/2013US20130266597 Small Cationic Antimicrobial Peptides
10/10/2013US20130266592 Companion animal treatments
10/10/2013US20130266537 Moesin modulators and uses thereof
10/10/2013DE102012102998A1 New polymer comprising two substances that bind to amyloid-beta-oligomers, useful for treating Alzheimer's disease, Parkinson's disease, Creutzfeldt Jakob disease or diabetes
10/09/2013EP2647647A2 Thiopeptide precursor protein, gene encoding it and uses thereof
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2261378B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins
10/09/2013CN103342739A Antigenic mimic epitope of fumonisin B1 and application thereof
10/09/2013CN103342738A Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein
10/09/2013CN103342737A Caspase 3-sensitive fluorescence enhancement nano developer and preparation method thereof
10/09/2013CN103342736A Synthesis method of telaprevir
10/09/2013CN103342735A Tumor specific target polypeptide and application thereof
10/08/2013US8552152 Compositions and methods for modulating dopamine neurotransmission
10/08/2013US8552148 TNF-α antagonists containing IGFBP5
10/08/2013US8552147 Peptides and compositions for prevention of cell adhesion and methods of using same
10/08/2013US8552145 Vaccine for modulating between T1 and T2 immune responses
10/08/2013US8551949 Methods for treatment of pain
10/08/2013US8551789 Frizzled-binding agents and their use in screening for WNT inhibitors
10/08/2013US8551723 Tyrosine kinase-inducible domains
10/08/2013US8551493 Peptide with reduced dimer formation
10/08/2013US8551492 Vaccine peptide combinations against cat allergy
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/03/2013WO2013148296A1 Antibodies to bradykinin b1 receptor ligands
10/03/2013WO2013148214A1 Modulating disease through genetic engineering of plants
10/03/2013WO2013147512A1 Biotin-linked hexapeptide-2 derivative and uses thereof
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013143501A1 Hydrate of cyclopeptide compound as well as preparation method and use thereof
10/03/2013WO2013143499A1 High-purity cyclopeptide crystal as well as preparation method and use thereof
10/03/2013WO2013143497A1 High purity cyclopeptide compound as well as preparation method and use thereof
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013US20130261286 Process for preparing caspofungin and novel intermediates thereof
10/03/2013US20130261285 Method for preparing atosiban acetate
10/03/2013US20130261066 Treatment of inflammatory bowel diseases using a tripeptide
10/03/2013US20130261064 N-carboxyalkyl-auristatin and the use thereof
10/03/2013US20130261048 Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase
10/03/2013US20130259929 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
10/03/2013US20130259884 Peptides
10/03/2013US20130259883 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
10/02/2013EP2643342A1 Novel angiotensin type 2 (at2) receptor agonists and uses thereof
10/02/2013EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
10/02/2013EP2170930B3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
10/02/2013CN103339253A TOMM34 peptides and vaccines including the same
10/02/2013CN103339142A Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
10/02/2013CN103333252A Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
10/02/2013CN103333227A Metastatic tumor deletion protein small-molecule cyclopeptide inhibitor as well as preparation method and application thereof
10/02/2013CN103333226A Polypeptide marker SPG04 for nasopharyngeal darcinoma radiosensitivity, and ELISA kit prepared by same
10/02/2013CN103333225A Antibacterial peptide, preparation method and applications thereof
10/02/2013CN103333224A Avian influenza virus NS1 protein B cell epitope polypeptide and applications thereof
10/02/2013CN103333223A A novel blood-glucose-reducing polypeptide and applications thereof
10/02/2013CN102627686B Polypeptide with effect of inhibiting activity of fibroblast growth factor receptor 3 and application thereof
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 423